Showing 141 - 160 results of 152,679 for search '(( 2 a decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (mean decrease)) ))', query time: 1.15s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145

    Increased oxidative stress, viral load and decreased survivability of N2a following RIG-I ablation. by Arshed Nazmi (215284)

    Published 2011
    “…<p>Flow cytometric analysis carried out from cells of all treatment groups to detect intracellular JEV antigen showed significant increase post RIG-I ablation when compared to only JEV-infected or JEV+ScMO groups. The mean fluorescence intensities obtained from each group are depicted in the figure. (1-Unstained, 2-Mock-infected; 3-JEV-infected, 4-JEV+Sc-MO, 5-JEV+rMO) (A). …”
  6. 146
  7. 147

    EGCG decreases RSK2-mediated cell viability. by Hanyong Chen (320863)

    Published 2015
    “…Differences were evaluated using the Student’s t-test and the asterisk (*) indicates a significant decrease in viability in RSK2<sup>+/+</sup> MEFs compared to RSK2<sup>-/-</sup> MEFs (<i>p</i> < 0.05).…”
  8. 148

    Activation of mitoK<sub>ATP</sub> channels decreased the latency time of the transjunctional currents in slice. by Jiangping Wang (281901)

    Published 2013
    “…<p>(<b>A</b>) Currents in S<sub>cell</sub> induced by a pair of ±160 mV voltage steps and the transjunctional currents received by the R<sub>cell</sub>. …”
  9. 149
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155

    Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

    Published 2013
    “…B) For ascorbic acid, the ANOVA model did not detect group-specific changes over time (no group:time interaction), but indicated significant decreases from T0 to T6 in both groups. Overall, 1,5-anhydrosorbitol and ascorbic acid were significantly different at each time point between OB and OB/D subgroups (p<0.01, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-t002" target="_blank"><b>TABLE 2</b></a>).…”
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160